Actifed DM

Quick links to important sections

Actifed DM

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Actifed DM

Quick Facts

Property Description
Active Ingredients Dextromethorphan Hydrobromide, Pseudoephedrine, Triprolidine
Form Oral tablet or liquid/syrup solution
Pharmacological Class Antihistamine-decongestant-antitussive combination
Common Use Symptomatic relief of upper respiratory and cold-related discomforts
Origin Synthetic derivative combination

What Type of Medicine is Actifed DM?

Actifed DM is an oral, fixed-dose combination product classified as an antihistamine-decongestant-antitussive combination. This formulation, which is a synthetic derivative combination, is available for patient use as a tablet or as an oral solution (liquid or syrup form). The combination format is clinically recognized for its efficiency in addressing concurrent symptoms, a key differentiating factor from single-ingredient treatments. The preparation is explicitly designed to consolidate the actions of different drug classes into a single medicine, offering a unified approach to multi-symptom respiratory discomfort.

Actifed DM: Identifying the Three Active Ingredients

The identity of this medicine is defined by its three distinct active ingredients: Dextromethorphan Hydrobromide, Pseudoephedrine, and Triprolidine. Dextromethorphan is a non-narcotic antitussive agent that acts centrally to suppress the cough reflex. Pseudoephedrine is specifically an alpha-Adrenergic Agonist, meaning it is a sympathomimetic decongestant that causes localized vasoconstriction in the nasal passages. The structural data confirms that Pseudoephedrine is a compound designed to reduce swelling in the airways. The third component, Triprolidine, is a first-generation antihistamine that is an H1 receptor antagonist, used to block the inflammatory effects of histamine released by the body. The product is a combination used to address coughs and common cold symptoms.

General Purpose of the Multi-Action Formula

The general purpose of this formula is to provide coordinated symptomatic relief by leveraging its three distinct mechanisms concurrently. This ensures that the medicine addresses three separate physiological concerns: it provides cough suppression, relieves airway decongestion by reducing mucosal edema, and controls allergic responses, such as a runny nose and sneezing, through allergy symptom blockade. This unified action is the primary benefit of the formula, particularly useful in neutral scenarios where a patient experiences a concurrent cough, blocked nose, and mild allergy symptoms. This multi-action formula allows the patient to target the combined symptom profile often associated with upper respiratory irritation using a single oral preparation.

Regulatory References

  1. Actifed DM drug label on DailyMed
  2. Dextromethorphan, pseudoephedrine, and triprolidine combination information
  3. NIH MedlinePlus Drug Information

What side effects are possible with Actifed DM?

Possible Side Effects and Safety Information

The official safety profile for the Actifed DM combination, which includes Dextromethorphan, Pseudoephedrine, and Triprolidine, details adverse reactions primarily organized by frequency and affected body systems. The most frequently documented adverse effects are related to Central Nervous System (CNS) depression and anticholinergic activity, categorized as Common in regulatory documentation.

Key Adverse Reaction Categories

Classification Examples of Documented Effects
Common Effects Drowsiness, sedation, dizziness, dry mouth, dry nose, dry throat, and headache.
System-Organ Classes Nervous System Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, and Renal and Urinary Disorders.

CNS effects like drowsiness may be more noticeable at the initiation of treatment. The sympathomimetic component (Pseudoephedrine) may contribute to effects like nervousness, tachycardia (increased heart rate), and palpitations within the official listings.

Serious Adverse Reactions and Safety Constraints

Regulatory documentation highlights risks of Serious Adverse Reactions, which are rare, including severe hypersensitivity reactions (such as anaphylaxis) and the potential for a hypertensive crisis, particularly when used concurrently with Monoamine Oxidase Inhibitors (MAOIs).

Safety notes specify constraints for specific populations and pre-existing conditions. Caution is required for older adults due to increased susceptibility to sedative and peripheral anticholinergic effects (e.g., urinary retention). Use is restricted in patients with severe uncontrolled hypertension, severe coronary artery disease, or conditions like narrow-angle glaucoma, as per regulatory labeling.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Actifed DM


Overdose Scope

Property Description
Documented Overdose Presentations Symptoms include both CNS excitation (agitation, confusion, rapid heartbeat, tremor) and CNS depression (drowsiness, somnolence, dizziness, loss of coordination). Other signs include nausea, vomiting, blurred vision, and changes in blood pressure or body temperature.
Physiological Systems Affected (as stated in label) Central Nervous System, Cardiovascular System, Respiratory System, and the Thermoregulatory System.
Dose-related or Exposure-related Factors (if applicable) Overdose occurs following administration of doses higher than those officially recommended, resulting in high circulating concentrations of the active ingredients.
Population-specific Overdose Notes (if applicable) Children are at increased risk for toxicity. Patients with existing severe renal impairment are at increased risk for cerebral adverse events.
Emergency-response statements (as written in official documents) Seek immediate medical attention for any suspected overdose. Call emergency services or a Poison Control Center right away.
When immediate medical help is required (label-derived phrasing only) Urgent help must be sought if the person has collapsed, had a seizure, has trouble breathing, cannot be awakened, or exhibits symptoms like a sudden severe headache or visual disturbances.

Overdose Classifications (high-level)

Property Description
Severity Classification (as defined in official documents) Overdose can lead to life-threatening complications, including seizures, coma, respiratory depression, severe hypertension, and Serotonin Syndrome.
Regulatory Basis (EMA / FDA / etc.) Information is derived from government-authorized prescribing information, public assessment reports, and regulatory monographs covering the toxicity profiles of the combination's components.
Overdose-context constraints (as defined in official documents) Management requires symptomatic and supportive care in a hospital setting and is not managed by a single specific antidote.

Resulting Overdose Structure

Official overdose statements:

  • The primary management strategy is symptomatic and supportive treatment, including the use of Activated charcoal to reduce absorption.
  • Naloxone is documented for use in the management of overdose to reverse associated central nervous system and respiratory depression.
  • Monitoring includes mandatory checks of vital signs, ECG, and diagnostic blood and urine tests in the hospital setting.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the Actifed DM overdose profile through the concurrent risk of central nervous system excitation and depression, alongside severe cardiovascular risks. This dual toxicity dictates the mandated action to seek immediate medical attention for all suspected overdose scenarios and determines the specific supportive measures authorized for clinical use.

Therapeutic Uses of Actifed DM

What Actifed DM Treats: Main Uses and Benefits

Actifed DM is commonly used across therapeutic domains involving acute symptomatic discomfort associated with the common cold, flu-like illnesses, and allergic rhinitis. This combination product is used for managing a dry, persistent cough and is relevant for easing symptoms such as nasal congestion, runny nose, sneezing, and watery eyes. It is applied in scenarios where additional management of discomfort is required for a specific cluster of symptoms that create noticeable interference with daily stability.

The medication is commonly used across conditions presenting with acute episodes of dry, irritating cough, upper airway congestion (blockage that creates noticeable physiological strain), and allergic rhinitis (manifestations like sneezing and rhinorrhea). In these contexts, the formula contributes to easing the overall symptom load. This supportive action assists with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.


Quick Fact: Symptomatic Relief

Property Description
Symptom Clusters Dry cough, nasal congestion, runny nose, sneezing
Therapeutic Context Used in situations involving certain distressing symptoms
Primary Benefit Provides support that helps ease the overall symptom burden
Use Scenarios Applied during phases when symptoms become more noticeable

Regulatory References

  1. NIH DailyMed

Eligibility and Restrictions for Use

Eligibility for Actifed DM: Official Regulatory Status

The eligibility for Actifed DM, a combination product containing Dextromethorphan, Pseudoephedrine, and Triprolidine, is strictly defined by regulatory documents, distinguishing between approved, restricted, and contraindicated populations.

Category Regulatory Status Eligibility Group
Allowed Approved Use Adults and Children aged 12 years and over (in approved regions).
Contraindicated Absolute Non-Use MAOI use (within 14 days), severe hypertension, severe coronary artery disease, severe kidney failure, diabetes mellitus, hyperthyroidism, closed angle glaucoma, and respiratory failure [SmPC 2.1, 4.2].
Restricted Use with Caution Patients with moderate renal impairment, hepatic impairment, prostatic hypertrophy, or chronic cough (e.g., due to asthma) [SmPC 2.1, 4.2].

Use is generally contraindicated in children under 12 years across many jurisdictions. For pregnancy and lactation, the medicine should not be used unless the potential benefit is deemed to outweigh the possible risks by a physician, as safe use is not established [SmPC 2.1, 4.3].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Actifed DM is classified by regulatory authorities based on contraindicated combinations and specific pharmacodynamic and pharmacokinetic interaction risks. This medicine must not be given to patients currently taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping MAOI treatment, due to the documented risks of hypertensive crisis and Serotonin Syndrome.

Classification Description (as defined in official documents)
Contraindicated Combinations MAOIs, Beta-Blockers, and other Sympathomimetic Agents (e.g., decongestants, appetite suppressants) [Source 2.1, 2.7].
Pharmacodynamic Interactions Alcohol and CNS Depressants may enhance the sedative effects of the Triprolidine component. Serotonergic agents (e.g., SSRIs) carry a risk of Serotonin Syndrome with Dextromethorphan [Source 2.1].
Pharmacokinetic Interactions Co-administration with CYP2D6 inhibitors may result in the exaggerated and/or prolonged effects of Dextromethorphan due to reduced clearance [Source 2.1].

In addition to the contraindicated list, the Pseudoephedrine component may partially reverse the hypotensive action of certain antihypertensives (e.g., methyldopa). Caution is also advised for use in patients with hepatic or moderate to severe renal impairment, as the medicine's effects may be increased due to slower removal from the body [Source 2.2, 2.7]. The regulatory profile is defined by these strict interaction rules, which govern co-administration to mitigate potential cardiovascular and central nervous system risks. (197 words)

Mechanism of Action

How Actifed DM Works

The overall mechanism of Actifed DM is defined by the simultaneous modulation of three distinct physiological systems, resulting from the actions of its three active ingredients on core pathways.


Central Suppression of the Cough Reflex

The central component, Dextromethorphan, acts as an agonist on Sigma-1 receptors (sigma1) in the brainstem's medullary cough center. This molecular action modulates the neurological reflex pathway by suppressing synaptic transmission. The resulting physiological consequence is an elevation of the cough reflex threshold.


Autonomic Control of Nasal Swelling

The decongestant mechanism, driven by Pseudoephedrine, relies on the agonism of Alpha-1 adrenergic receptors (alpha1) located on the smooth muscle of arterioles in the nasal mucosa. The mechanism acts within the Sympathetic Autonomic Nervous System by initiating vasoconstriction of the small blood vessels. This constricts blood flow and minimizes fluid leakage, which decreases mucosal edema (swelling) of the tissues.


Blockade of Humoral Signaling and Secretions

Triprolidine provides a dual-action mechanism by functioning as a competitive antagonist at the Histamine H1-receptor and exhibiting anticholinergic activity. By blocking histaminergic signaling and reducing parasympathetic stimulation, the mechanism prevents histamine-mediated increases in vascular permeability and inhibits glandular function. This action produces the physiological consequence of suppressed mucosal fluid secretion and maintenance of microvascular integrity.

Dosage and Administration Information

The administration of Actifed DM is restricted to the oral route, utilizing the liquid solution (syrup/linctus) formulation. The dosage pattern is based on a fixed unit dose and a specific minimum time interval between administrations.


Administration Protocol

Instruction Classification Official Guidance
Route of Administration Oral use only.
Dosing Schedule The standard single unit dose for adults and children aged 12 years and over is 10 ml of the oral solution.
Frequency Pattern Dosing is administered every 4 to 6 hours as required.
Maximum Daily Limit A maximum of 4 doses (total 40 ml) is permitted in any 24-hour period.

Procedural and Population Constraints

The procedural framework involves accurate measurement of the unit dose and strict adherence to the stated frequency pattern to ensure the total daily intake does not exceed the regulatory limits. For cases requiring alternative intake conditions, the oral solution may be prepared by diluting it at a ratio of 1:1 or 1:3 using unpreserved Syrup BP.

Regarding specific populations, the established adult dosage is deemed appropriate for older adults. Conversely, official documentation advises that caution must be exercised when administering the medicine to patients presenting with moderate renal impairment or hepatic impairment, necessitating dose consideration. In some regulatory jurisdictions, the use of this specific product is contraindicated in children younger than 12 years, establishing a definitive age-eligibility requirement for its use. This protocol, grounded in regulatory specifications, defines the standardized application of the medicine, ensuring precise unit dosing and controlled scheduling intervals.

Recent Clinical Evidence

Research evidence / Overview of studies for Actifed DM

Evidence for Use in Multi-Symptom Relief of the Common Cold

Research has studied this combination medicine in research contexts exploring its use for the multiple acute symptoms often associated with a common cold or upper respiratory tract infection. The evidence base relies on a landscape of Randomized Controlled Trials (RCTs) and Systematic Reviews that have explored how symptoms change over time.

In these studies, researchers monitored various patient-reported outcomes describing perceived discomfort, such as changes in overall symptom severity scores, the subjective measure of nasal stuffiness, the presence of a runny nose (rhinorrhea), and the severity and frequency of coughing. Findings related to the research of the combination for cold symptoms have been noted to be mixed. Research describes patterns observed in the studies, particularly that evidence for the cough-suppressing component (dextromethorphan) often shows findings were mixed compared to an inactive control (placebo). Overall, the certainty remains low to moderate for the general category of over-the-counter cough and cold combinations.


Evidence for Use in Allergic Rhinitis Symptoms

Actifed DM was evaluated in research contexts involving conditions characterized by fluctuating or episodic manifestations, specifically for symptoms associated with allergic rhinitis (hay fever). The core evidence here often focuses on RCTs of the dual combination of the antihistamine and decongestant components.

These trials focused on outcomes linked to inflammatory or irritative states, measuring the perceived discomfort from symptoms such as sneezing and runny nose, and also included objective measures of nasal airflow to evaluate the outcomes related to the decongestant component. Research describes patterns observed in the studies where measurements related to relief for these primary allergic symptoms were taken. However, data are still emerging on the specific utility of the third component, the antitussive, when the primary condition is limited to allergic rhinitis alone.


Follow-up and Duration of Clinical Studies

The clinical research available for this combination medicine typically reflects the acute nature of the conditions studied. Studies generally focus on episodes where symptoms become more noticeable. As a result, the follow-up durations were limited. Most trials were short-term treatment studies, lasting from a single dose up to a maximum of about three to seven days.

Key Studies & References Summary of the evidence | Cough (acute): antimicrobial prescribing | Guidance (Based on Cochrane reviews for Antitussives)

Frequently Asked Questions (FAQ)

Common questions about Actifed DM (FAQ)

Q: How long does it typically take for Actifed DM to start working? (Onset)

Official pharmacokinetic data describes the onset of action for the active ingredients. The decongestant component (pseudoephedrine) is described as typically beginning to exert its effect within 30 minutes of administration. The antihistamine component (triprolidine) generally takes 1 to 2 hours to exert its effect.

Q: What is the expected duration of Actifed DM's effect?

The duration of the therapeutic effect varies by ingredient, but the decongestant component is stated in official documents to last for at least 4 hours. This duration generally aligns with the product's defined dosing interval, which is listed as 4 to 6 hours.

Q: What types of foods or drinks are commonly advised to avoid when taking Actifed DM?

According to the official product information, consuming alcohol while taking Actifed DM may enhance the sedative effects of the antihistamine component. For the liquid formulation, individuals with diabetes should also be aware of the sucrose (sugar) content listed in the product's excipients.

Q: Is Actifed DM classified as a controlled substance?

Actifed DM is not generally listed as a federally controlled substance. However, one of its ingredients, pseudoephedrine, is subject to specific sales restrictions and monitoring because it can be used in the illegal manufacture of methamphetamine.

Q: Why is Actifed DM sometimes kept behind the counter?

The reason for its restricted placement is related to the decongestant ingredient, pseudoephedrine. This component is subject to specific federal and local sales regulations because it can be misused as a precursor chemical to manufacture illegal drugs.

Q: Is there a risk of dependency or withdrawal described for Actifed DM?

Official regulatory documents contain warnings stating that the prolonged use of this product may lead to drug dependence (addiction). Regulatory documents note that usage should be kept within the limits defined on the official labeling.

Q: What is the difference between Actifed and Actifed DM?

The difference lies in the active ingredients included in the formula. Actifed DM is a multi-action combination containing Dextromethorphan (a cough suppressant) in addition to an antihistamine and a decongestant. The standard Actifed formula typically contains only the antihistamine and decongestant ingredients.

Q: Can Actifed DM interact with herbal supplements like St. John's Wort?

Official interaction data indicates that certain herbal supplements, such as St. John’s Wort, may interact with the dextromethorphan component. This interaction may potentially raise the risk of developing high serotonin levels, which is why co-administration is generally not recommended in official information.

Q: Can Actifed DM affect the results of a drug test?

Official drug interference information notes that the ingredient dextromethorphan can cause cross-reactivity with certain laboratory tests. This means there is a potential for a false-positive result for phencyclidine (PCP) on initial urine drug screening.

Q: Is it true that Actifed DM can affect your sleep?

Official regulatory documents list insomnia (difficulty falling or staying asleep) and other sleep disturbances as possible side effects. The product contains components that can affect the central nervous system, which may explain these sleep-related effects.

Q: Can Actifed DM cause stomach upset or nausea?

Official product information states that common side effects include gastrointestinal disturbances such as nausea and vomiting. These effects are typically documented with a classification of common occurrence in patient populations.

Q: What are the signs of a serious allergic reaction to Actifed DM?

Serious allergic reactions, including severe hypersensitivity (anaphylaxis), are rare but documented in official safety information. Signs that have been documented as requiring rapid evaluation include an unusual fever, the sudden appearance of many small pustules on the skin, or difficulty breathing.

Q: Does Actifed DM typically make you thirstier?

Actifed DM contains a component with anticholinergic activity, which commonly results in effects like a dry mouth, dry nose, and dry throat. This common side effect can make a person feel like they are thirstier than usual.

Q: Are there any warnings about operating machinery while using Actifed DM?

Regulatory warnings explicitly state that this medicine may cause side effects like drowsiness and dizziness. Official warnings state that activities such as driving a vehicle or operating heavy machinery must be avoided if these effects are experienced.

Q: Does taking Actifed DM regularly affect liver function?

The medicine's components are metabolized primarily by the liver, and official documents advise caution for patients with existing hepatic (liver) impairment. Liver disorder is also listed as a rare adverse reaction, meaning it has been documented but occurs infrequently.

Q: Is Actifed DM approved for use in asthma patients?

Official labeling states that use is restricted for individuals with a persistent or chronic cough, such as one associated with asthma or chronic bronchitis. This restriction is included in the warnings section of the drug information.

Q: Are there any common skin reactions associated with Actifed DM?

Regulatory documents describe rare skin reactions such as rash and allergic dermatitis associated with the medicine. There have also been reports of severe skin reactions linked to the pseudoephedrine component.

Q: Can Actifed DM cause confusion or memory issues in older adults?

Official safety information notes that confusion is a documented side effect of Actifed DM. Older adults are specifically noted as being more prone to developing cognitive effects like confusion when taking this type of medication.

How should Actifed DM be stored and disposed of?

How to Store and Dispose of Actifed DM

Actifed DM must be stored strictly according to the conditions defined in the regulatory labeling to maintain product stability and safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature (15 C to 30 C) or below 25 C for specific formulations.
Protection Keep the medicine in its original container, tightly closed, and protect it from excess heat, light, and moisture.
Child Safety The product must be stored out of the sight and reach of children and safety caps should always be locked.

Disposal Instructions

Actifed DM must be discarded in accordance with local requirements. The preferred method for disposal is utilizing a drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance (such as dirt or coffee grounds) and placed in a sealed container before disposal in the household trash. The product must not be flushed down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Actifed DM found in:

A-Z Index: